RG7697 / Roche  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RG7697 / Roche
NCT01951183: A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin

Withdrawn
2a
0
US
Placebo, RO6811135
Hoffmann-La Roche
Diabetes Mellitus Type 2
12/13
12/13
NCT02205528: A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Completed
2a
108
US
Liraglutide, Metformin, Placebo, NNC0090-2746
Novo Nordisk A/S
Diabetes, Diabetes Mellitus Type 2
09/15
09/15

Download Options